SNCA and Parkinson disease: MSC-Exos significantly reduced NLRP3-induced inflammation and cytosolic protein kinase 5 (CDK5)-related nigrostriatal autophagy; moreover, they decreased dopaminergic neuronal apoptosis and inflammation while inhibiting α-synuclein aggregation in PD mice (Li et al. 2021).